| Typicality: | 0.366 |
| Saliency: | 0.271 |
| months following the last trastuzumab dose | 6 | temporal |
| on day 1 of cycles | 4 | temporal |
| sample → be collected at → baseline | 11 |
| sample → be taken at → baseline | 7 |
| sample → be collected at → the baseline | 4 |
| negative | neutral | positive |
| 0.099 | 0.829 | 0.073 |
| Raw frequency | 22 |
| Normalized frequency | 0.271 |
| Modifier score | 0.500 |
| Perplexity | 63.826 |